Profile
DRUG VRTX REGN VRNA ARGX ALNY
Company Name Bright Minds Biosciences Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $627.40M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Ian McDonald Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
DRUG VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
DRUG VRTX REGN VRNA ARGX ALNY
Last Close $58 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $69.41 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $23.27 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -16.44 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 149.25 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
DRUG VRTX REGN VRNA ARGX ALNY
1 Month Return -8.14 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 27.33 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 75.76 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 54.63 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 61.02 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 56.46 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DRUG VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1738323.8 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
DRUG VRTX REGN VRNA ARGX ALNY
Asset Growth 1282.92 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -234.59 % 9.09 % -131.37 % 24.59 %
Net Income Growth -336.46 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 70.65 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -374.03 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -864.26 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -432.65 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -237.29 % - -143.33 % -107.98 %
Operating 3 Year CFG 83.5 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -302.92 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -2666.07 % -100 % 40.15 % 97.08 %
EPS Growth -96.92 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -96.92 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 828.63 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 100.69 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 1404.02 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 8519.02 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 5.73 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -237.29 % - -144.48 % -201.54 %
Updated On 30 Sep 2025 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
DRUG VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -14.49 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -19.77 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -19.02 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 78.33 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -6910.34 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.03 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.21 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.21 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 1157.9 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -6910.34 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -97.35 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -89.61 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -89.61 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
DRUG VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.28 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
DRUG VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.08B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.08B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
DRUG VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.2
AARD Aardvark Therapeutics, Inc. Common Stock 12.28
ABCL AbCellera Biologics Inc. 2.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.39
ABPWW 0.0131
ABSI Absci Corporation 2.42
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.54
ACAD ACADIA Pharmaceuticals Inc. 21.61
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.72
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ETFs With Exposure to DRUG
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.01407 259.54
IWO iShares Russell 2000 Growth ETF 0.02711 331.12
GWX SPDR S&P International Small Cap ETF 0.065074 45.32
HDG ProShares Hedge Replication ETF 0.00158321 52.7299
UWM ProShares Ultra Russell2000 0.00917753 51.76
VTHR Vanguard Russell 3000 Index Fund 0.00052 301.137
IWC iShares Micro-Cap ETF 0.09142 164.58
URTY ProShares UltraPro Russell2000 0.00715007 60.76
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.055143 47.5
SMMD iShares Russell 2500 ETF 0.01 79.71
VFMO Vanguard U.S. Momentum Factor ETF 0.07391 202.62
VTWG Vanguard Russell 2000 Growth Index Fund 0.0258 241.62
VTWO Vanguard Russell 2000 Index Fund 0.01325 104.9
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 49.11
VMO.TO Vanguard Global Momentum Factor ETF 0.11065 83.78
BMED BlackRock Future Health ETF 0.25705 30.35
IBRN iShares Neuroscience and Healthcare ETF 0.87987 31.6847
PSIL AdvisorShares Psychedelics ETF 4.63 16.108
ITDG iShares Trust 0 39.05
ITDI iShares Trust 0 39.045
ITDH iShares Trust 0 39.03
ITDF iShares Trust 0 38.51
ITDC iShares Trust 0 34.97
ITDB iShares Trust 0 33.695
ITDD Integrated Data Corp. 0 36.38
ITDE iShares Trust 0 37.43
RSSL Global X Funds 0.01 101.72
ITDJ iShares Trust 0 30.33
RESM Columbia Research Enhanced Small Cap ETF 0.01 21.141
Unlock